期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Intracameral lidocaine as supplement to classic topical anesthesia for relieving ocular pain in cataract surgery 被引量:4
1
作者 Marcella Nebbioso Maria Luisa Livani +2 位作者 Valentina Santamaria aloisa librando Massimiliano Sepe 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2018年第12期1932-1935,共4页
AIM: To evaluate safety, efficacy, and patient adherence of intracameral lidocaine as supplement of classic topical anesthetic drops in cataract surgery.METHODS: A prospective and controlled trial including a large co... AIM: To evaluate safety, efficacy, and patient adherence of intracameral lidocaine as supplement of classic topical anesthetic drops in cataract surgery.METHODS: A prospective and controlled trial including a large cohort of 1650 individuals suffering with bilateral cataract not complicated, in program by phacoemulsification surgery, were randomly assigned to 2 different groups for the type of anesthesia received, 0.4% oxybuprocaine hydrochloride(INN) drops, and INN drops associated to intracameral 1% lidocaine hydrochloride monohydrate. At the end of surgery, tables were assigned to each patient indicating the degree of pain(0-3) felt during the operation.RESULTS: Thirty-two percent of patients in group 1 declared to have not felt any pain against the 77% of patients in group 2. Fifty-nine percent of patients in group 1 complained about only a slight discomfort against 20% of group 2 patients. Only a small percentage of patients in group 1(5%) admitted severe pain, while no patient in group 2 admitted severe pain. Four patients of group 2 reported an episode of transient amaurosis, lasting several hours after surgery.CONCLUSION: Intracameral administration of lidocaine is a simple and secure method able to increase the analgesia during the cataract surgery, eliminating the discomfort and increasing also the cooperation of the patients during the steps of manipulation. 展开更多
关键词 benoxinate cataract surgery LIDOCAINE oxybuprocaine pain scores PHACOEMULSIFICATION
原文传递
Effectiveness of 0.1% topical salicylic acid on blepharoconjunctivitis affecting glaucoma patients treated with topical prostaglandin analogues:a prospective randomized trial 被引量:2
2
作者 aloisa librando Sandra Cinzia Carlesimo +3 位作者 Giorgio Albanese Giuseppe Maria Albanese Raffaele Migliorini Elena Pacella 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2018年第12期1936-1940,共5页
AIM: To evaluate the efficacy of 0.1% topical salicylic acid(TSA) to treat iatrogenic chronic blepharoconjunctivitis in patients with primary open angle glaucoma(POAG), treated with topical prostaglandin analogues... AIM: To evaluate the efficacy of 0.1% topical salicylic acid(TSA) to treat iatrogenic chronic blepharoconjunctivitis in patients with primary open angle glaucoma(POAG), treated with topical prostaglandin analogues(TPAs).METHODS: Totally 60 patients were randomly distributed into 3 equal size groups, two of which treated with 0.1% TSA(OMKASA;) and 0.1% topical clobetasone butyrate(TCB; VISUCLOBEN;) respectively, and one consisting of untreated controls. The parameters taken into account at baseline(T0) and after 30 d(T1) of therapy were: conjunctival hyperemia, lacrimal function tests [Schirmer I test and break up time(BUT)] and intraocular pressure(IOP).RESULTS: Conjunctival hyperemia showed a substantial improvement in both treated groups(P<0.001) but not among controls. Similarly, lacrimal function tests displayed an improvement of Schirmer I test in both treated groups(P<0.05) and an extension of BUT only in the group treated with 0.1% TSA(P<0.05). The IOP increase was statistically significant only in those patients treated with 0.1% TCB(P<0.001).CONCLUSION: The 0.1% TSA has proved to be an effective anti-inflammatory treatment of blepharoconjunctivitis affecting glaucoma patients on therapy with TPAs, leading to a sizeable decrease of inflammation as well as both quantitative and qualitative improvement of tear film. Furthermore, differently from 0.1% TCB, it does not induce any significant IOP increase. 展开更多
关键词 blepharoconjunctivitis GLAUCOMA intraocular pressure lacrimal function tests prostaglandin analogues topical clobetasone butyrate topical salicylic acid
原文传递
Nd: Yag laser iridotomy in Shaffer-Etienne grade 1 and 2: angle widening in our case studies
3
作者 Sandra Cinzia Carlesimo Luigi Di Santo +3 位作者 Pietro Bruni aloisa librando Antonietta Pompea Falace Andrea Barbato 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2015年第4期709-713,共5页
·AIM: To obtain widening of a potentially occludable angle, in according to Kanski’s indications, through preventive Nd:Yag laser iridotomy. The observational study was performed by using gonioscopy for the sele... ·AIM: To obtain widening of a potentially occludable angle, in according to Kanski’s indications, through preventive Nd:Yag laser iridotomy. The observational study was performed by using gonioscopy for the selection and follow-up of 1165 treated eyes and exploiting Shaffer-Etienne gonioscopic classification as a quality/quantity test of the angle recession.·METHODS: Between September 2000 and July 2012,586 patients were selected at the Outpatients’ Ophthalmological Clinic of the Policlinico Umberto I of Rome in order to undergo Nd: Yag laser iridotomy. A Goldmann type contact lens, Q-switched mode, 2-3defocus, and 7-9 m J intensity with 2-3 impulse discharges were used for surgery.·RESULTS: From as early as the first week, a whole360° angle widening were evident in the patients, thus showing the success of Nd:Yag laser iridotomy in solving relative pupil block. The angle remained narrow by 270° in 14 eyes only, despite repetitions of further treatment with laser iridotomy in a different part of the iris, twice in 10 eyes and three times in 4 eyes.·CONCLUSION: Nd:Yag laser iridotomy revealed itself as being a safe and effective treatment in widening those critical Shaffer-Etienne grade 1 and 2 potentially occludable angles. 展开更多
关键词 GLAUCOMA GONIOSCOPY intraocular pressure iridotomy narrow angle Nd:Yag laser
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部